A novel machine learning algorithm called B-SOiD quickly and efficiently analyzes animal behaviors, and may be useful in assessing movement disorders in people with Parkinson’s disease. Researchers described their findings in the study, “B-SOiD, an open-source unsupervised algorithm for identification and fast prediction of behaviors,” published in Nature…
Many people with Parkinson’s disease have misconceptions about routine vaccinations, with more than one of 10 patients thinking they are not recommended for people with Parkinson’s — even though they very much are, as they can be life-saving. The results, based on a survey of patients in the U.S.,…
A $200,000 gift from the Cargill family will help to support studies into gait that is affected by Parkinson’s disease. The money, from the estate of Bob and Sara Lou Cargill and given by their daughter Sara Beth Lee and her husband John Lee, who has Parkinson’s, will go toward…
Transcranial stimulation — a noninvasive procedure that sends low-level electric currents to certain brain regions — may boost the benefits of aerobic exercise and improve gait for people with idiopathic Parkinson’s disease, a small study reports. “We found that transcranial stimulation activated the pre-frontal cortex, a brain region that Parkinson’s…
Women who are older when going through menopause appear to be at a lower risk of developing Parkinson’s disease, according to a study based on genetic data. These findings support the idea that certain sex hormones may protect the brain from this disease. The study, “Increased…
A Virginia Commonwealth University (VCU) team is developing immersive virtual reality “games” to help those with movement disorders, including Parkinson’s disease. Led by James S. Thomas, PhD, a physical therapy professor, the multidisciplinary science team at VCU’s Motor Control Lab in the College of Health Professions hope these…
Top-line data from a Phase 3 clinical trial testing IPX-203 showed Amneal Pharmaceuticals’ carbidopa-levodopa (CD/LD) extended-release capsules work better than immediate-release tablets at reducing “off” time in people with advanced Parkinson’s disease and motor fluctuations. These benefits were observed even when IPX-203 was taken two times less…
Shape Therapeutics and Roche have entered into a strategic collaboration and license agreement to develop RNA-based gene therapies for Parkinson’s, Alzheimer’s, and rare diseases. Under the terms of the agreement, Shape will use its proprietary RNA technologies to leverage molecular machinery already present in human cells to…
PINK1 and Parkin — two proteins whose deficiency has been linked to early-onset Parkinson’s — are involved in the degradation and recycling of mitochondria in neurons, a study shows. While these proteins were known to contribute to mitochondrial recycling in other cell types, this study provides a closer look into mitochondria’s…
The Parkinson’s Foundation announced it will invest $4.3 million in 29 grants for projects that will investigate the underlying causes of Parkinson’s disease and its biological mechanisms, with the goal of finding new treatments. This investment is in addition to the $10 million the Foundation committed to spend earlier this year. “The…
Get regular updates to your inbox.